(Q33359457)

26 July 2017

1 reference

title

The side-effect profile of GM-CSF (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1493936

2 October 2022

author name string

A. C. Stern

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1493936

2 October 2022

T. C. Jones

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1493936

2 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1493936

2 October 2022

publication date

1 January 1992

1 reference

26 July 2017

1 reference

26 July 2017

volume

20 Suppl 2

1 reference

26 July 2017

page(s)

S124-7

1 reference

A Phase I/II Trial of Zidovudine, Interferon- , and Granulocyte-Macrophage Colony-Stimulating Factor in the Treatment of Human Immunodeficiency Virus Type 1 Infection

26 July 2017

cites work

1 reference

12 December 2020

Characterization of the clinical effects after the first dose of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor

1 reference

12 December 2020

Emerging clinical uses for GM-CSF.

1 reference

12 December 2020

Correction of granulocytopenia in Felty's syndrome by granulocyte-macrophage colony-stimulating factor. Simultaneous induction of interleukin-6 release and flare-up of the arthritis

1 reference

12 December 2020

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression

1 reference

12 December 2020

Reversible thyroid dysfunction during treatment with GM-CSF

1 reference

12 December 2020

Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy

1 reference

12 December 2020

Failure of recombinant human granulocyte-macrophage colony-stimulating factor therapy in aplastic anemia patients with very severe neutropenia

1 reference

12 December 2020

Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions--a phase I dose-toxicity study

1 reference

12 December 2020

The use of GM-CSF as an adjunct to autologous/syngeneic bone marrow transplantation: a prospective randomized controlled trial

1 reference

12 December 2020

Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01705031

1 reference

Dimensions Publication ID

26 July 2017

1029107304

0 references

1 reference